Online inquiry

IVTScrip™ mRNA-Human ACO1, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A))   (CAT#: GTTS-WK12431MR)

This product GTTS-WK12431MR is a type of mRNA having 120 nt poly(A) tail and modified with Cap 0 & 5-Methyl-CTP & Pseudo-UTP. It ecodes the ACO1 protein. This product can be used in Oogenesis phase fetal germ cell-related researches.
Specifications
Product type mRNA
Modified bases 5-Methyl-CTP & Pseudo-UTP
5' Cap Cap 1
Species Human
RefSeq NM_001278352.2
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 48
UniProt ID P21399
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human ACO1, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) (GTTS-WK12431MR). Click the button above to contact us or submit your feedback about this product.

See other products
CAT Product Name Product Type CDs
GTTS-WK21153MR IVTScrip™ mRNA-Human Aminopeptidase-N, (Cap 1, 5-Methyl-CTP, 30 nt-poly(A)) mRNA Aminopeptidase-N
GTTS-WK1487MR IVTScrip™ mRNA-Human GPX3, (Cap 0, 5-Methyl-CTP, 120 nt-poly(A)) mRNA GPX3
GTTS-WK11551MR IVTScrip™ mRNA-Human ACSM2A, (Cap 1, 5-Methoxy-UTP, 120 nt-poly(A)) mRNA ACSM2A
GTTS-WK9520MR IVTScrip™ mRNA-Human ADCY3, (Cap 0, N1-Methylpseudo-UTP, 30 nt-poly(A)) mRNA ADCY3
GTTS-WK27813MR IVTScrip™ mRNA-Human ASH2L, (Cap 1, 5-Methoxy-UTP, 30 nt-poly(A)) mRNA ASH2L
GTTS-WK2773MR IVTScrip™ mRNA-Human CD309, (Cap 0, 2-Thio-UTP, 30 nt-poly(A)) mRNA CD309
GTTS-WK8809MR IVTScrip™ mRNA-Human ACADSB, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA ACADSB
GTTS-WK10948MR IVTScrip™ mRNA-Human ACSL4, (Cap 1, Pseudo-UTP, 120 nt-poly(A)) mRNA ACSL4
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
×

Webinar Register

Simone Pinto Carneiro, Ph.D.

Group Leader, Ludwig-Maximilians-University of Munich

date-time 10 AM EDT | May 19, 2026

Register Now →